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Abstract 
Understanding neuroadaptations involved in obesity is critical for developing new 
approaches to treatment. Diet-induced neuroadaptations within the dorsal striatum have 
the capacity to drive excessive food seeking and consumption. Five week old C57BL/6J 
mice consumed a high-fat, high-sugar ‘western diet’ (WD) or a control ‘standard diet’ 
(SD) for 16 weeks. Weight gain, glucose tolerance, and insulin tolerance were 
measured to confirm an obese-like state. Following these 16 weeks, 
electrophysiological recordings were made from medium spiny neurons (MSNs) in the 
medial (DMS) and lateral (DLS) portions of dorsal striatum to evaluate diet effects on 
neuronal excitability and synaptic plasticity. In addition, fast-scan cyclic voltammetry 
evaluated dopamine transmission in these areas. WD mice gained significantly more 
weight and consumed more calories than SD mice and demonstrated impaired glucose 
tolerance. Electrophysiology data revealed that MSNs from WD mice demonstrated 
increased AMPA to NMDA receptor current ratio and prolonged spontaneous 
glutamate-mediated currents, specifically in the DLS. Evoked dopamine release was 
also significantly greater and reuptake slower in both subregions of WD striatum. 
Finally, dorsal striatal MSNs from WD mice were significantly less likely to demonstrate 
mu-opioid receptor-mediated synaptic plasticity. Neuronal excitability and GABAergic 
transmission were unaffected by diet in either striatal subregion. Our results 
demonstrate that a high-fat, high-sugar diet alters facets of glutamate, dopamine, and 
opioid signaling within the dorsal striatum, with some subregion specificity. These 
alterations within a brain area known to play a role in food motivation/consumption and 
habitual behavior are highly relevant for the clinical condition of obesity and its 
treatment.   
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Introduction 
 Obesity and its related health issues (e.g. diabetes) are associated with 
increased mortality and morbidity and the cost to society (e.g. healthcare, lost work 
days, etc.) is great (Flegal, 2005; Flegal et al., 2013; Haslam and James, 2005; Hedley 
et al., 2004; Jia and Lubetkin, 2010; Stice et al., 2008b). It is believed that the ease of 
access to and the low cost of highly palatable, high calorie foods is largely responsible 
for the ‘obesity-epidemic’ (Swinburn et al., 2011). It is estimated that over 70% of U.S. 
adults meet criteria for being overweight or obese (Fryar et al., 2016). The tremendous 
extent of this issue necessitates further understanding of how brain function may be 
altered in obese individuals to more accurately assess risk factors and explore novel 
treatment options. 
The dorsal striatum is a brain region with known involvement in habitual and 
compulsive behaviors, including food seeking and binge-like eating (Balleine, 2005; 
Furlong et al., 2014; Wang et al., 2011; Yin et al., 2004). Furthermore, the dorsal 
striatum plays a role in homeostatic energy consumption (Palmiter, 2008), thus, 
dysfunction may contribute to the continuation of food consumption when already sated. 
Clinical research has demonstrated that the motivation to consume and hedonic 
properties of food are associated with increased DA signaling in the dorsal striatum of 
healthy, hungry subjects (Small et al., 2003; Volkow et al., 2002), implying that the 
rewarding value of food is encoded by dorsal striatal DA signaling. Studies directly 
examining neuronal functioning in the dorsal striatum of obese individuals, however, 
have yielded mixed findings. Data from imaging studies are apparently equivocal, 
providing evidence of both increases (Rothemund et al., 2007; Wang et al., 2011; 
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Yokum et al., 2014) and decreases (Babbs et al., 2013; Stice et al., 2008a; Volkow et 
al., 2011; Wang et al., 2001) in the activity of the dorsal striatum related to 
obesity/overeating disorders. It is important to bear in mind, however, that obesity may 
be distinct in its neural mechanisms relative to other overeating disorders. Preclinical 
studies in rodent models also demonstrate significant alterations in various aspects of 
glutamate and DA signaling in the brain (Auer et al., 2015; Berridge et al., 2010; Brown 
et al., 2017; Cano et al., 2014; Charles et al., 2015; Fordahl and Jones, 2017; Johnson 
and Kenny, 2010; Sickmann et al., 2010; Speed et al., 2011; Stamatakis et al., 2016; Xu 
et al., 2013). However, very little is known about effects within the dorsal striatum, 
specifically.  
 Although the data are not currently clear, the available evidence generally 
suggests that obese individuals exhibit altered neurotransmission, in some capacity, in 
the dorsal striatum relative to healthy controls. The nature and mechanisms of these 
functional differences, however, are poorly understood. In the current study, we set out 
to evaluate the electrophysiological and neurochemical effects of sustained 
consumption of a high-fat, high-sugar ‘western diet’ in the mouse dorsal striatum. 
Alterations in these measures may offer potential mechanisms of neurocircuitry 
adaptations relevant to obesity. As the medial (DMS) and lateral (DLS) portions of the 
dorsal striatum exhibit differential control over goal-directed versus habitual food 
seeking in rodents respectively (Yin et al., 2004),  we examined these parameters 
separately in each subregion. 
 
Methods 
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Animals 
 Male C57BL/6J mice (N=23; subset of 15 mice used for 
electrophysiology/neurochemistry) were ordered from the Jackson Laboratory (Bar 
Harbor, ME, USA) at 4 weeks of age and allowed 7 days to habituate to the vivarium 
space prior to experimentation. All mice were group housed 3-4 per cage and 
maintained on a standard 12 hr light/dark cycle (lights ON at 0700). The temperature 
and humidity of the vivarium space were held constant at 20°C and 50%, respectively. 
Following the 7 day acclimation period, all animals had ad libitum access to water and 
either a high-fat, high sugar ‘western diet’ (WD) or a control ‘standard diet’ (SD) (3 
cages SD, 3 cages WD). All procedures reported herein were approved by the Indiana 
University School of Medicine Institutional Animal Care and Use Committee and closely 
followed the guidelines for the care and use of laboratory animals as promulgated by 
the National Institutes of Health. 
Diets 
 Mouse diets were purchased from Envigo (Madison, WI, USA). The key metrics 
of each diet are presented in Table 1. Mice were fed either SD (Envigo TD.08485) or 
WD (Envigo TD.88137) for 16 weeks. 
Obesity model monitoring 
 Mice were weighed weekly to determine whether WD animals were gaining 
significantly more weight than SD mice. Once a week, a food intake was measured over 
a specific 24 hr period. Food intake was determined by the weight difference between 
the amount of food initially in the cage and the remaining food after the 24 hr period. 
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Using these data, energy consumption was recorded as kcal/mouse/cage. Given that 
obesity has become increasingly associated with the development of type 2 diabetes, 
we also evaluated common early assessments of pre-diabetic risk: glucose tolerance 
and insulin tolerance.  
 Glucose tolerance 
 Animals were fasted for 16 hours prior to assessment the following morning. All 
mice were weighed and a baseline (Time ‘0’) blood glucose reading was taken via a 
glucometer sampling from a small cut to the tail vein. Animals were then injected 
intraperitoneally with 1 g/kg D-glucose (Sigma Aldrich, St. Louis, MO, USA) at a volume 
of 4 ml/kg. Blood glucose readings were then taken at 10, 20, 30, 60, 90, and 120 
minutes post-injection. 
Insulin tolerance 
  Animals were fasted for 2 hrs prior to assessment. All mice were weighed and a 
baseline (Time ‘0’) blood glucose reading was taken via a glucometer sampling from a 
small cut to the tail vein. Animals were then injected intraperitoneally with 0.75 U/kg 
human insulin Humulin-R (Eli Lilly, Indianapolis, IN, USA) at a volume of 3 ml/kg. Blood 
glucose readings were then taken at 15, 30, 45, and 60 minutes post-injection.  
Brain slice preparation 
 Mice were sacrificed via decapitation under deep isoflurane anesthesia and the 
brain was rapidly excised and placed into ice-cold, continuously 95% CO2/5% O2 
bubbled cutting solution containing:  30 mM NaCl, 4.5 mM KCl, 1 mM MgCl2, 26 mM 
NaHCO3, 1.2 mM NaH2PO4, 10 mM glucose and 194 mM sucrose. 300 µm coronal 
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brain slices containing the striatum were prepared on a Leica VT1200S vibratome. For 
electrophysiology experiments, sections were rapidly transferred to 32°C, continuously 
95% CO2/5% O2 bubbled artificial cerebrospinal fluid (aCSF) containing: 124 mM NaCl, 
4.5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 26 mM NaHCO3, 1.2 mM NaH2PO4 and 10 
mM glucose. For fast scan cyclic voltammetry, the aCSF contained: 126 mM NaCl, 1.2 
mM NaH2PO4, 2.4 mM CaCl2, 1.2 mM MgCl2, 2.5 mM KCl, 0.4 mM L-ascorbic acid, 20 
mM HEPES, 11 mM D-glucose, 25 mM NaHCO3.  After incubating for ~1h, slices were 
moved to a 21°C environment until recording. 
Electrophysiology 
Whole-cell voltage and current clamp recordings were made using a Multiclamp 700B 
and Digidata 1550B amplifier (Molecular Devices, Sunnyvale, CA, USA). For recording, 
brain slices were moved to the recording chamber which was held at 32°C and 
continuously perfused with 95% CO2/5% oxygenated aCSF at a rate of ~1.5ml/min. 
Slices were visualized on an Olympus BX51WI microscope (Olympus Corporation of 
America). Recordings were made from GABAergic medium spiny neurons (MSNs) in 
medial and lateral regions of the dorsal striatum. MSNs make up the vast majority (~ 
95%) of neurons in the rodent striatum (Tepper et al., 2007) and are the region’s sole 
output neuron type. MSNs were confirmed by their membrane resistance and 
capacitance. Drugs were prepared as stock solutions and diluted in aCSF to their final 
concentrations and used on the same day. Drugs were administered to brain slices via 
bath application, in which normal aCSF was replaced with aCSF containing drug. 
Borosilicate glass recording pipettes of 2-4 MΩ were filled with specific internal solutions 
(see below) for whole cell recordings. Internal solutions were adjusted to 295–310 
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mOsm. All whole-cell recordings were filtered at 2 kHz and digitized at 10 kHz. Data 
were acquired using Clampex 10 (Molecular Devices). Series resistance was monitored 
and only cells with a stable series resistance (less than 25 MΩ and that did not change 
more than 15%) were included for data analysis. 
Excitability 
In order to determine whether diet consumption influenced the excitability of 
MSNs in the DMS and DLS, increasing current steps (-200 pA to 400 pA in 50 pA 
increments) were applied at 500 ms intervals and action potentials were recorded in 
current clamp mode. The K-gluconate internal solution used in these experiments 
consisted of: 4 mM KCl, 10mM HEPES, 4 mM MgATP, 0.3 mM NaGTP, 10 mM 
phosphocreatine, 126 mM K-gluconate. The excitability parameters recorded included: 
resting membrane potential, action potential threshold, action potential peak amplitude, 
action potential half-width, input resistance, and action potential frequency. Calculations 
of the action potential threshold, peak amplitude, and peak half-width were generated 
with data collected from the first current step that produced action potentials.     
Excitatory transmission 
In order to isolate excitatory transmission in these experiments, the aCSF 
contained 50 µM picrotoxin (potent antagonist of the GABAA receptor). All of these 
experiments were conducted in voltage clamp mode (-60 mV holding potential, unless 
otherwise noted). A Teflon-coated bipolar stimulating electrode (PlasticsONE, Roanoke, 
VA) was placed at the border of the corpus callosum and the DLS or DMS. The internal 
solution contained: 120 mM CsMeSO3, 5 mM NaCl, 10 mM TEA-Cl, 10 mM HEPES, 5 
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mM lidocaine bromide, 1.1 mM EGTA, 0.3 mM Na-GTP and 4 mM Mg-ATP. Once a cell 
was successfully patched, stimulation was produced via a DS3 Isolated Current 
Stimulator (Digitimer, Ft. Lauderdale, FL, USA) and the intensity was adjusted until a 
stable excitatory postsynaptic current (EPSC) response between -200 to -400 pA was 
achieved. At this point, 3 different assessments of excitatory transmission commenced 
with each cell.  
Spontaneous EPSCs (sEPSCs) were measured over the course of 5 min of gap-
free recording in the absence of any form of electrical stimulation. Measured sEPSC 
parameters included: frequency, amplitude, rise time, and the decay constant. AMPA to 
NMDA receptor-mediated current ratios were measured by first holding the cell at -80 
mV and electrically-evoking an AMPAR-mediated EPSC. The NMDAR current was 
determined by holding the membrane potential at +40 mV and electrically-evoking an 
EPSC. Since the AMPAR component of EPSCs at -80 mV was not apparent 100 ms 
following the electrical stimulus (i.e. the measured current returned to baseline), we 
calculated the NMDAR-mediated portion of the EPSC at +40 mV as the average of the 
measured current over the following 25 ms (i.e. 100-125 ms post-stimulus). Finally, 
paired-pulse ratios (25-200 ms between pulses) were also measured to determine if the 
probability of presynaptic neurotransmitter release differed between treatment groups. 
sEPSCs were measured first, so that repeated stimulation required by the 
AMPAR/NMDAR ratio and paired-pulse ratio experiments did not influence sEPSC 
parameters. 
Inhibitory transmission 
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In different cells, spontaneous inhibitory GABAA receptor-mediated currents 
(sIPSCs) were recorded in the absence of any electrical stimulation over the course of 5 
min. To block excitatory transmission, the aCSF contained 5µM NBQX (AMPAR 
antagonist) and 50 µM AP5 (NMDAR antagonist). In addition, the internal solution 
contained: 60 mM CsMeSO3, 60 mM CsCl2, 10 mM HEPES, 0.2 mM EGTA, 8 mM 
NaCl, 2 mM MgCl2, 3 mM MgATP, 0.3 mM NaGTP, 5 mM lidocaine, 10 mM 
phosphocreatine. sIPSC parameters included: frequency, amplitude, rise time, and the 
decay constant. 
Mu-opioid receptor-mediated plasticity 
A role for the mu-opioid receptor (MOPr) in binge-like, compulsive eating has 
been identified (Colantuoni et al., 2002; Cooper and Turkish, 1989; Cottone et al., 2008; 
Doyle et al., 1993; Drewnowski et al., 1992; Ferraro et al., 2002; Katsuura and Taha, 
2010; Kirkham and Cooper, 1988). Experiments in rodents demonstrate that the DMS 
and DLS subregions of the dorsal striatum contribute to goal-directed and habitual food 
seeking, respectively (Yin et al., 2004). Therefore, MOPr function in dorsal striatum is 
likely an important factor in various food consumption phenotypes. Similar to our 
previous work (Atwood et al., 2014), we examined MOPr-mediated long term synaptic 
plasticity in DMS and DLS MSNs. In order to do this, EPSCs (at -60 mV) were 
electrically evoked every 20 s as described above. After a stable 10-min baseline, the 
selective MOPr agonist [D-Ala2, NMe-Phe4, Gly-ol5]-enkephalin (DAMGO; Bachem, 
Bubendorf, Switzerland) was washed on to the slice for a 5-min period at a 
concentration of 0.3 µM. EPSCs continued to be recorded following DAMGO application 
for a total of 40 minutes of recording. Plasticity was assessed by comparing the average 
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EPSC peak amplitude for the final 10 min of recording to the average for the 10 min 
baseline (Atwood et al., 2014). 
Neurochemistry 
 Electrically-evoked DA release in DLS and DMS was measured via in vitro fast-
scan cyclic voltammetry (FSCV). For a detailed description of the technique, see Heien 
et al. (2004). After brain slice preparation and incubation as described above, slices 
were transferred to the FSCV recording chamber which was continuously perfused (~1 
ml/min) with 95% CO2/5% oxygenated FSCV aCSF. All slices were from brains also 
used in electrophysiology experiments. FSCV electrodes were constructed by aspirating 
a single carbon fiber in a glass capillary tube. The tube was then tapered by a pipette 
puller, thus sealing the glass tightly around the fiber. The protruding fiber was cut to a 
length between 100-150 µM. The fiber of the electrode was inserted ~75 µM into the 
DMS or DLS. A bipolar stimulating electrode locally applied a 4 ms, monophasic, 350 
µA current every 5 min using a DS4 Bi-phasic Stimulus Isolator (Digitimer). Recordings 
were made using Demon Voltammetry software (Wake Forest University, Wake Forest, 
NC, USA) and custom-built recording equipment. Electrically-evoked DA was measured 
by applying a triangular voltage waveform to the recording electrode: -0.4 to +1.2 to -0.4 
V relative to a Ag/AgCl reference electrode at a rate of 400 V/s every 100 ms. Once a 
stable response was achieved, an average of 3 evoked DA peaks per recording site 
was calculated. Parameters measured included: peak amplitude (quantification of peak 
DA levels), tau (measure of peak decay duration), peak half-life, peak half-width, T20 
(time at which measured DA is 20% lower than the measured peak), and T80 (time at 
which measured DA is 80% lower than the measured peak). FSCV recording electrodes 
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were calibrated after experimental data collection by adding 1 µM dopamine to the 
perfusate. Measured DA during data collection was inferred on the basis of this post-
hoc calibration peak. 
Statistical Analysis    
 Unless otherwise noted, all data graphing and analysis was conducted with 
GraphPad Prism 7.0 software (GraphPad Software, Inc., La Jolla, CA, USA). Weight 
and in kcal consumption were analyzed by repeated measures ANOVAs with diet as 
between subjects factor and week as the within subjects factor. Glucose tolerance test 
(GTT) and insulin tolerance test (ITT) data were analyzed via unpaired t-tests of the 
area under of the curve. With the exception of synaptic plasticity data, all other data 
were analyzed via 2-factor ANOVAs with diet and brain region as between subjects 
factors. For opioid plasticity data, a categorical analysis of the distribution of 3 different 
classifications of plasticity was calculated. Group assignment of individual cells was 
initially done visually, then confirmed via t-tests vs. baseline: long-term depression 
(average EPSC amplitude of final 10 min < baseline average amplitude), long-term 
potentiation (average EPSC amplitude of final 10 min was > baseline average 
amplitude), or no change. The observed distribution of cells into these classifications 
within the WD and SD groups was compared to an expected distribution, given that the 
null hypothesis is true. The statistical method of comparison used calculates the degree 
to which the observed values differ from the expected values and these are quantified 
as ‘adjusted residuals’ (Agresti, 2007; Sharpe, 2015). Adjusted residual values in 
excess of 3.0 are considered statistically significant. Where appropriate, Sidak’s multiple 
comparisons test was used for post-hoc comparisons and the level of significance for all 
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analyses was set at p < 0.05. Due to technical issues, 4 WD, 4 SD mice were not tested 
for insulin tolerance and were therefore not included in ITT analyses. 
 
Results 
Obesity model monitoring 
 Mice fed the WD gained significantly more weight (F1,21 = 31.74, p < 0.001; 
Figure 1A) over the course of the experiment and a significant interaction with time 
(F14,294 = 24.8, p < 0.001) indicated that this was true at week 7 and beyond (post hoc 
p’s < 0.01). WD mice also consumed significantly more kilocalories than mice fed the 
SD over the 16-week monitoring period (F1,64 = 29.21, p < 0.001; Figure 1B). SD mice 
also gained weight and increased their caloric intake, however this was expected as all 
mice began the study at ~5 weeks of age. The ITT conducted at week 12, however, 
found no difference between the diet groups (p = 0.323; Figure 1C,D). Insulin 
tolerance/resistance is associated with a more advanced type 2 diabetic phenotype 
(Reaven, 1988). Thus, 12 weeks of WD exposure may not have been sufficient to 
influence insulin sensitivity. Nevertheless, significantly impaired glucose tolerance, an 
important pre-diabetic correlate of obesity (Sinha  et al., 2002), was observed in WD 
mice at week 16 (t21 = 2.84, p < 0.001; Figure 1E,F). Impaired glucose tolerance is 
considered a reliable correlate of insulin resistance (Winzell and Ahrén, 2004). 
Unfortunately, we were unable to evaluate insulin resistance at week 16 due to 
technical issues. 
Electrophysiology 
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 Excitability 
 No significant differences in excitability parameters were detected between SD 
and WD mice in either dorsal striatal subregion (Figure 2A-E). Resting membrane 
potential, action potential threshold, action potential half-width, action potential peak 
amplitude, and input resistance were all similar in MSNs from the DLS and DMS in WD 
and SD mice (all main effects and interactions p’s > 0.09). Furthermore, action potential 
frequency during increasing current steps was not different between SD and WD MSNs 
in both the DMS and DLS (p’s > 0.46; Figure 2F-H). 
 Excitatory transmission 
 Statistical analysis of the AMPAR/NMDAR current ratio found a significant 
interaction of diet and brain region (F1,31 = 7.2, p < 0.05; Figure 3A,B), with post-hoc 
testing indicating that WD MSNs exhibited a significantly greater AMPAR/NMDAR 
current ratio than those from SD mice specifically in the DLS (p < 0.05). Paired-pulse 
ratio (PPR) analysis did not reveal any significant differences between WD and SD cells 
in the likelihood of glutamate release in either the DLS or DMS (p’s > 0.63; Figure 3C-
E). The analysis of sEPSCs indicated a significant interaction of diet and brain region for 
the decay constant (F1,29 = 7.57, p < 0.05; Figure 4A,E), with post-hoc testing revealing 
that the decay of spontaneous EPSCs back to baseline was significantly slower in WD 
relative to SD recordings, specifically in DLS (p < 0.01). Other sEPSC parameters (rise 
time, frequency, amplitude) were not different between WD and SD cells (all p’s > 0.2; 
Figure 4B-D). Main effects of region for sEPSC frequency (F1,27 = 4.7, p < 0.05) and 
amplitude (F1,29 = 11.83, p < 0.051), however, indicated significantly larger and more 
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frequent sEPSCs in DMS relative to DLS.  Cumulative probability plots for all sEPSC 
parameters in Figure 5 demonstrate the relative distribution of values for all cells. 
 Inhibitory Transmission 
 Spontaneous IPSC parameters (frequency, amplitude, rise time, decay constant) 
were not statistically different between SD and WD cells in both the DLS and DMS (all 
p’s > 0.23; Figure 6A-E). A main effect of region for amplitude (F1,21 = 4.57, p < 0.05) 
and decay constant (F1,21 = 8.0, p < 0.05), however, indicated that these parameters 
were significantly greater in DLS. Cumulative probability plots for all sIPSC parameters 
in Figure 7 demonstrate the relative distribution of values for all cells. 
Mu-opioid receptor-mediated plasticity 
Although the overall analysis revealed no difference between SD and WD cells in 
the response to DAMGO, a MOPr agonist, (Figure 8A,B), the distribution of outcomes 
revealed a clear difference (Figure 8C). Across both dorsal striatal subregions, 
collectively, the WD condition exhibited a substantial number of cells (6/11 cells) 
demonstrating no change from ESPC baseline amplitude following DAMGO application, 
whereas no SD cells (0/13) received this designation. A categorical analysis of adjusted 
residuals of expected values revealed that this was indeed a significant difference 
between SD and WD conditions (absolute value of adjusted residual was > 3.0). 
Conversely, all SD cells were determined to demonstrate some form of plasticity, either 
long-term depression or long-term potentiation. Therefore, WD cells demonstrated a 
significant reduced responsivity/plasticity in response to MOPr activation via DAMGO in 
the dorsal striatum. 
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Electrochemistry 
 Electrically-evoked DA release was significantly higher across the dorsal striatal 
subregions in WD compared to SD slices (F1,20 = 26.01, p < 0.001; Figure 9A,B). 
Furthermore, measures of DA uptake/clearance kinetics indicated that DA clearance 
was significantly less efficient in WD dorsal striatum. Tau (measures of peak decay 
duration) values were significantly larger for WD recordings (F1,20 = 22.88, p < 0.001; 
Figure 9C), indicating slower rate of DA peak decay. Additionally, tau values were 
generally larger in the DMS relative to the DLS (F1,20 = 14.12, p < 0.01). The same 
pattern of results (WD and DMS > than SD and DLS) was consistent in the other 
uptake/clearance measures (Figure 9D-F): half-life (Diet: F1,20 = 23.06, p < 0.001; 
Region: F1,20 = 13.15, p < 0.01), half-width (Diet: F1,20 = 17.64, p < 0.001; Region: F1,20 = 
14.02, p < 0.01), and T80  (Diet: F1,20 = 30.09, p < 0.001; Region: F1,20 = 12.57, p < 0.01). 
No difference between groups/regions was detected for T20 (p’s > 0.2; not shown). 
Overall, these data indicate that evoked DA release was significantly greater and uptake 
was significantly less efficient in WD relative to SD dorsal striatum.  
 
Discussion 
 In the present study, an obese-like phenotype was observed in mice exposed to 
a high-fat, high-sugar diet (WD). These animals gained significantly more weight and 
consumed more kilocalories than mice fed the control (SD) diet. Importantly, WD mice 
also demonstrated impaired glucose tolerance after 16 weeks of diet exposure; an 
important pre-diabetic correlate of obesity (Sinha  et al., 2002). When evaluating 
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synaptic function in the dorsal striatum of these animals, we observed that the obese-
like phenotype was associated with altered glutamate transmission specifically in the 
DLS as well as greatly enhanced DA transmission throughout the dorsal striatum. 
These findings offer novel insight into the neural mechanisms affected by high-fat, high-
sugar diet consumption and their potential role in excessive, non-homeostatic feeding 
behavior. 
 We found that basal excitability parameters of dorsal striatal MSNs were 
unaffected by diet. Although unlikely, it is possible that smaller current steps (i.e. < 50 
pA) could have uncovered some subtle differences in excitability parameters. 
Nevertheless, we observed significantly altered glutamate function in the DLS of WD 
mice. The decay time for presynaptic glutamate-driven sEPSCs was significantly 
prolonged in the DLS of WD MSNs. The lack of difference in the amplitude of these 
currents (in addition to null PPR data) suggests that presynaptic glutamate release 
dynamics were unaffected. Therefore, the most parsimonious explanation for these data 
is that glutamate uptake is slower in the DLS of WD mice. As GLT-1 is the primary 
glutamate transporter in dorsal striatum (Rothstein et al., 1994), GLT-1 function may 
have been decreased as a consequence of WD consumption. GLT-1 is the predominant 
glutamate transporter in the CNS, and ~80-90% of its expression in the brain is found 
on astrocytes (Murphy-Royal et al., 2017; Rimmele and Rosenberg, 2016; Rothstein et 
al., 1994). A loss of GLT-1 function prolongs the presence of glutamate in the synaptic 
cleft, thus producing a longer duration of glutamate synaptic activity and increases the 
probability of glutamate-induced synaptic adaptations. Some previous work has 
demonstrated that high fat diet consumption in mice produces an increase in GLT-1 
  
18 
 
expression and function at hippocampal synapses which alters basal synaptic 
transmission and subsequently reduces glutamate receptor-mediated synaptic plasticity 
(Cano et al., 2014; Valladolid-Acebes et al., 2012). On the other hand, many 
neurological disorders produce a down-regulation of GLT-1 expression (Soni et al., 
2014). One indication of glutamate transporter functional changes is in the kinetics of 
glutamate-mediated synaptic currents (Murphy-Royal et al., 2015). A decrease in 
transporter function results in slower EPSC decay (Marcaggi et al., 2003; Weng et al., 
2007), as was observed in the current study. GLT-1 dysfunction has been implicated in 
many diseases including substance use disorders, neurodegenerative and 
neuroinflammatory diseases, and epilepsy (Petr et al., 2015; Roberts-Wolfe and 
Kalivas, 2015; Soni et al., 2014). 
Additionally, the glutamate-driven AMPAR/NMDAR current ratio was significantly 
reduced in DLS MSNs of WD mice relative to SD mice. Given the lack of group 
differences in sEPSC amplitude, this effect is likely not due to increased AMPAR 
expression. An alternative explanation is that AMPAR subunit composition may have 
been altered by prolonged WD diet consumption. Indeed, AMPAR subunit composition 
substantially influences the functional dynamics (including EPSC decay time and peak 
amplitude) of AMPARs (Lomeli et al., 1994). Therefore, altered AMPAR subunit 
composition may explain the observation of increased sEPSC decay time, however this 
is not a likely explanation for the observed increase in AMPAR/NMDAR ratio given the 
lack of difference in sEPSC amplitude. An alternative may be that NMDAR expression 
or function is reduced. It is important to note that AMPAR and NMDAR currents were 
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not pharmacologically isolated (i.e. use of antagonists NBQX and APV). As such, we 
cannot rule out that our measured currents are purely AMPAR- or NMDAR-mediated. 
NMDARs are involved in controlling feeding behavior, body weight, and glucose 
homeostasis (Campos and Ritter, 2015; Doane et al., 2007; Guard et al., 2009a, b; 
Khan et al., 1999; Resch et al., 2014; Ritter, 2011; Stamatakis et al., 2016; Stanley et 
al., 1996; Uner et al., 2015; Wright et al., 2011; Wu et al., 2013). NMDARs are also 
important for developing a preference for high fat diet (Buttigieg et al., 2014). The 
NMDAR blocker memantine, normally used to treat Alzheimer’s disease, reduces 
palatable food consumption in rodents and non-human primates (Bisaga et al., 2008; 
Popik et al., 2011; Smith et al., 2015) and may positively impact binge eating in 
humans, although its effectiveness on weight loss has been inconsistent (Brennan et 
al., 2008; Hermanussen and Tresguerres, 2005). Memantine also reduces compulsive 
food seeking behavior in rodents, suggesting dorsal striatal circuits could be involved in 
addition to mesolimbic circuits (Smith et al., 2015). This is consistent with its efficacy in 
treating compulsive behavior in humans as well (Ghaleiha et al., 2013). However, the 
synaptic mechanisms underlying NMDAR-mediated regulation of compulsive eating 
have not been elucidated. 
 Our electrochemical assessment of DA signaling revealed that DA transmission 
was greatly enhanced in WD mice across both subregions of the dorsal striatum. 
Clinical PET studies have observed that DA receptor binding in the dorsal striatum is 
positively associated with the motivation to obtain food and subjective ratings of ‘meal 
pleasantness’ in healthy individuals (Wang et al., 2001; Yokum et al., 2014). Findings 
from studies evaluating the response of the dorsal striatum to food cues or reward in 
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obese individuals are much less clear, however. Imaging studies note both increases 
(Rothemund et al., 2007; Wang et al., 2011; Yokum et al., 2014) and decreases (Babbs 
et al., 2013; Stice et al., 2008a; Volkow et al., 2011; Wang et al., 2001) in striatal 
activation in response to food reward or cues in obese individuals, or individuals that 
would later develop obesity. There is tremendous methodological variability in these 
studies (i.e. studying only women versus men and women, different levels of subject 
obesity, subjects were hungry or sated, cues tapping different sensory modalities, 
distinction of dorsal striatum or whole striatum) which is likely a key factor in the large 
degree of study discordance. A fairly recent study benefiting from methodological 
strengths (clear differentiation between dorsal and ventral striatum and control over 
previous energy intake in all subjects), demonstrated significantly greater D2 receptor 
binding potential in the dorsal striatum, but lower binding potential in the ventral 
striatum, of obese individuals relative to healthy controls (Guo et al., 2014). Collectively, 
these findings resemble a dominant theory in the extant drug and alcohol literature that 
a shift in activation from ventral to dorsal striatum governs an individual’s transition from 
recreational to habitual use (Everitt and Robbins, 2013). 
To our knowledge, this study is the first to address whether an obesogenic diet 
alters evoked DA release and uptake kinetics in the subregions of the dorsal striatum. 
We found that evoked DA release in both the DLS and DMS of WD mice was nearly 
twice that of SD mice. In addition, DA uptake parameters indicated that uptake was 
significantly slower across the dorsal striatal subregions of these mice. Thus, prolonged 
consumption of the WD diet resulted in enhanced DA transmission throughout the 
dorsal striatum. Impaired uptake/clearance is likely indicative of reduced DA transporter 
  
21 
 
(DAT) function or expression. Indeed, prior studies have observed a reduced DA 
clearance capacity in the nucleus accumbens core (Fordahl and Jones, 2017) and 
reduced membrane-bound DAT levels (Fordahl et al., 2016; Hryhorczuk et al., 2016; 
Speed et al., 2011) within the striatum and nucleus accumbens of mice fed a high-fat 
diet. Although not quantified, it is likely that our observations in the current study were 
also due to reduced DAT expression. While DA reuptake mechanisms were clearly 
affected, this previous voltammetry work in the nucleus accumbens core also observed 
that 6 weeks of high-fat diet consumption in mice had no effect on evoked DA release 
(Fordahl and Jones, 2017). The accumbens is commonly deemed analogous to the 
ventral striatum in humans and is thought to be a primary regulator of hedonic, reward 
processes (Carlezon and Thomas, 2009). The clinical observations of Guo and 
colleagues (2014) suggest that obesity is associated with elevated DA signaling in the 
dorsal striatum, but reduced DA signaling ventral striatum. Although Fordahl and Jones 
(2017) observed no alteration in evoked accumbal DA in mice fed a high fat diet, it is 
possible that the diet exposure period was not long enough and with more protracted 
exposure, DA levels may actually decrease. The current study did not evaluate 
accumbal DA dynamics, however we observed a robust increase in evoked DA release 
in the dorsal striatum of mice fed WD for 16 weeks. Enhanced non-hedonic motivation 
to obtain food is a correlate of enhanced dorsal striatal DA tone in clinical populations 
(Volkow et al., 2002). Future work should evaluate whether a longer exposure period to 
obesogenic diets models the ventral-to-dorsal shift in DA signaling observed in clinical 
work (Guo et al., 2014).   
  
22 
 
In our final experiment, we evaluated whether MOPr-mediated synaptic plasticity 
was altered by WD consumption. We found that dorsal striatal MSNs of WD mice were 
significantly lacking in MOPr plasticity relative to SD controls. The majority of MSNs 
from SD mice display typically observed MOPr-LTD (Atwood et al., 2014), while in a 
smaller proportion the MOPr agonist DAMGO produced long-term potentiation (MOR-
LTP). This is a previously unobserved phenomenon with an unknown mechanism. In 
mice that consumed WD for 16 weeks, MSN responses to DAMGO were significantly 
more heterogeneous. About 50% of cells displayed mOP-LTD or -LTP, but a group of 
neurons emerged that did not respond to DAMGO. These data indicate a subset of 
MSNs in WD-fed mice lose MOPr regulation of glutamate input. One explanation for 
both the heterogeneous response to WD as well as the two types of MOPr-mediated 
plasticity observed is that glutamate synapses are heterogeneous in both their 
originating cortical brain regions as well their target MSN type (direct or indirect pathway 
of striatal output) (Hunnicutt et al., 2016; Voorn et al., 2004; Wall et al., 2013). Direct 
pathway MSNs reinforce and promote behaviors, whereas indirect pathway neurons 
inhibit behavior. The balance of activity between the two determines behavioral output 
(Cui et al., 2013; Freeze et al., 2013; Kravitz et al., 2012). Direct pathway activation 
promotes feeding whereas indirect pathway activation inhibits feeding (Kenny et al., 
2013). Each type of MSN is approximately equally represented in dorsal striatum 
(Bateup et al., 2010). Some forms of glutamatergic synaptic plasticity occur at synapses 
on to only one class of these output pathways (Kreitzer and Malenka, 2007; Lerner et 
al., 2010; Nazzaro et al., 2012). A plausible explanation is that WD impairs plasticity at 
glutamate input selectively, in one of the pathways. Perhaps a simpler explanation is 
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that sustained WD consumption reduced MOPr levels in both the DMS and DLS. Prior 
work in rats demonstrated the MOPr mRNA is reduced across both subregions of the 
dorsal striatum after 3 months of a high-fat and high-sugar diet (Robinson et al., 2015). 
A reduction in MOPr expression in the current experiment could translate to the 
observed lack of MOPr-mediated plasticity throughout the dorsal striatum.  
MORs have been implicated in the consumption of fatty foods and binge-like 
eating (Colantuoni et al., 2002; Cooper and Turkish, 1989; Cottone et al., 2008; Doyle et 
al., 1993; Drewnowski et al., 1992; Ferraro et al., 2002; Katsuura and Taha, 2010; 
Kirkham and Cooper, 1988). Rodent work has also demonstrated that endogenous 
opioids surge in the dorsal striatum during the consumption of highly palatable food 
(DiFeliceantonio et al., 2012). We have previously observed that pretreatment with 
oxycodone (Atwood et al., 2014) similarly ablates dorsal striatal MOPr plasticity. This is 
intriguing considering the growing body of evidence that there are significant overlaps in 
the neurocircuitry underlying addiction and obesity/overeating (Kenny, 2011). The lack 
of a neural response to MOPr activation may be indicative of inflexible neurocircuitry. 
Given the known role for the dorsal striatum in goal-directed and habitual food/drug 
seeking (Corbit et al., 2012; Yin et al., 2004), this neural inflexibility may be associated 
with behavioral inflexibility disorders (i.e. compulsive consumption/seeking).     
Although the clinical condition of obesity is very complex and evidence suggests 
that individual differences in a variety of neurobehavioral parameters are critically 
important (Vainik et al., 2013), a number of theories characterizing the pathological shift 
in motivation to overeat have been developed. One theory is a dysregulation in 
dopamine (DA) signaling, suggesting that obese individuals exhibit a reduced DA 
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response to food consumption and reduced D2 receptor levels in reward circuitry (Stice 
et al., 2010). This theory argues that overconsumption of food is a compensatory 
mechanism to elevate the low level of DA signaling, thus manifesting in obesity. Another 
theory suggests that a dysregulation of energy balance (caloric) homeostasis makes it 
difficult for an individual to determine when sufficient calories have been consumed, 
resulting in pathological overeating (Dagher, 2010). Finally, a hedonic-shift theory 
suggests that the initial rewarding properties of highly palatable/caloric foods that are 
initially ‘liked’ in high-risk individuals lose their rewarding value over time and instead 
recruit neural mechanisms driving food ‘wanting’ (i.e. craving) (Berridge et al., 2010). 
While our findings here do not directly buttress any of these particular theories, the data 
do demonstrate that multiple neurotransmitter systems in dorsal striatum, including DA, 
are impacted by long-term western diet consumption and obesity. Given the key role of 
the dorsal striatum in the control of action, this dysfunction could be part of an 
underlying mechanism for each theory. As previously mentioned, the clinical condition 
of obesity is very complex and the degree to which a particular theory applies likely 
varies on a case-by-case basis.  
    In conclusion, the obese-like phenotype produced by prolonged WD 
consumption in mice resulted in focally prolonged sEPSCs, likely as a result of 
decreased glutamate buffering, and blunted NMDAR signaling within the DLS. DA 
transmission was also robustly elevated throughout the dorsal striatum of WD mice. 
These findings were accompanied by reduced presynaptic MOPr-mediated plasticity. 
Future work should address the therapeutic potential for targeting glutamate signaling 
within the DLS and/or dorsal striatal DA and opioid signaling. 
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Figure Captions 
Figure 1. WD consumption produces an obese-like state. Mice fed the ‘western’ diet 
(WD) A) gained significantly more weight and B) consumed significantly more calories 
than mice fed the control standard diet (SD). C,D) Although the insulin tolerance test 
(ITT) at week 12 found no effect of diet, E,F) the glucose tolerance test (GTT) at week 
16 revealed significantly impaired glucose tolerance in WD mice. n = 7-12; p** < 0.01, 
p*** < 0.001 vs. SD.  
Figure 2. Dorsal striatal medium spiny neurons (MSNs) from WD and SD mice do 
not differ in excitability parameters. Current clamp electrophysiological recordings 
revealed no differences between WD and SD MSNs in A) resting membrane potential, 
B) threshold potential, C) action potential half-width, D) action potential peak amplitude, 
E) input resistance. F,G) Increasing steps of injected current also revealed no 
differences in action potential frequency in either striatal subregion. H) Representative 
traces for 200pA of injected current in both dorsal striatal subregions. n = 5-12 cells per 
diet × subregion; 2-3 mice per condition. 
Figure 3. WD consumption increases the AMPAR/NMDAR specifically in the DLS, 
with no effect on the probability of presynaptic glutamate release. Voltage clamp 
recordings revealed A) elevated AMPAR to NMDAR current ratio within the DLS of WD 
relative to SD mice. B) Representative AMPAR and NMDAR traces from WD and SD 
cells. C) Representative PPR traces for 50 ms interstimulus interval in both dorsal 
striatal subregions. Paired pulse ratio analysis of presynaptic glutamate release 
probability in D) DLS and E) DMS also revealed no group differences. n = 5-10 cells per 
diet × subregion; 2-3 mice per condition. p* < 0.05, p** < 0.01 vs. SD. 
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Figure 4. WD consumption prolongs glutamategic sEPSCs specifically in the DLS. 
A) Recordings of spontaneous EPSCs (sEPSCs) demonstrated a prolonged decay 
period for sEPSCs within the DLS. Measures of B) sEPSC frequency, C) amplitude, D) 
and rise time revealed no diet-induced differences. E) Representative sEPSC traces 
from WD and SD cells. n = 5-10 cells per diet × subregion; 2-3 mice per condition. p* < 
0.05, p** < 0.01 vs. SD. 
Figure 5. Cumulative probability plots for sEPSC parameters in DLS and DMS. 
The noted increase in decay time in WD mice is apparent in the A) DLS, but not the E) 
DMS. No group differences were observed in B,F) interevent interval, C,G) amplitude, 
D,H) or rise time in either region. n = 5-10 cells per diet × subregion; 2-3 mice per 
condition. 
Figure 6. Diet did not influence spontaneous GABAergic inhibitory transmission 
in the dorsal striatum. Recordings of spontaneous IPSCs (sIPSCs) revealed no 
differences between diet groups for the average A) decay constant, B) sEPSC 
frequency, C) amplitude, or D) rise time in either region. E) Representative sIPSC 
traces in both dorsal striatal subregions. n = 5-8 cells per diet × subregion; 1 mouse per 
condition. 
Figure 7. Cumulative probability plots for sIPSC parameters in DLS and DMS. No 
group differences were observed in A,E) decay time, B,F) interevent interval, C,G) 
amplitude, D,H) or rise time in either region. n = 5-8 cells per diet × subregion; 1 mouse 
per condition. 
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Figure 8. WD consumption disrupts mu-opiod receptor (MOPr) plasticity in the 
dorsal striatum. A) Time series of electrically-evoked EPSC (eEPSC) averages over 
the 40 min recording session. B) Application of the MOPr agonist DAMGO (0.3 µM) did 
not reveal overall diet group differences in response to DAMGO. However, an 
examination of cell groupings C) revealed that there was a significant lack of response 
to DAMGO in WD cells. n = 11-13 cells; 2 mice per condition. p* < 0.05 for adjusted 
residual analysis relative to expected distribution. 
Figure 9. WD mice demonstrate a robust increase in evoked dopamine release 
and impaired reuptake across the dorsal striatum. A) Fast scan cyclic voltammetry 
(FSCV) quantification of electrically evoked dopamine (DA) release was significantly 
elevated in the dorsal striatum of WD mice. B) Representative FSCV traces in SD and 
WD slices. C-F) Measures of DA clearance/reuptake also demonstrate a significantly 
prolonged DA signal, indicating a reduced DA clearance capacity. n = 6 slice recordings 
per diet × subregion (3 recordings in rostral striatum slice and 3 recordings in caudal 
striatum slice x subregion x condition); 1 mouse per condition. p* < 0.05, p** < 0.01, p*** 
< 0.001 vs. SD. 
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Table 1. Content of standard and ‘western’ diets. 
 Standard Diet ‘Western’ Diet 
 
Kcal/g 
 
 
3.6 
 
4.5 
Protein (% kcal) 
 
19.1 15.2 
Carbohydrate (%kcal) 67.9 42.7 
 
Fat (%kcal) 
 
 
13.0 
 
42 
Sucrose (%kcal) 120.0 341.5 
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Highlights 
 
• 16 weeks of high-sugar, high-fat ‘western’ diet (WD) consumption generated an 
obese-like mouse phenotype 
 
• WD mice demonstrated altered glutamate transmission in medium spiny neurons 
in dorsolateral, but not dorsomedial striatum 
 
• Evoked dopamine release was augmented and reuptake impaired in medial and 
lateral regions of the dorsal striatum of WD mice 
 
• Dorsal striatal medium spiny neurons of WD mice were less likely to express mu-
opioid receptor-mediated synaptic plasticity 
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